Matthias Alder
Chief Executive Officer presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 79 698 $ in data 31/03/2024
Profilo
Matthias A.
Alder is currently the President, Chief Executive Officer & Director at Gain Therapeutics, Inc. and the Chief Executive Officer & Director at GT Gain Therapeutics SA. He is also a Director at Autolus Holdings (UK) Ltd., the Alliance For Artificial Intelligence In Healthcare, the New York State Bar Association, the Virginia Bar Association, and the Zurich Bar Association.
In his former positions, Mr. Alder worked as Counsel at Ciba-Geigy Corp.
and Novartis, Inc. He served as the Secretary & Executive VP-Corporate Development at Cytos Biotechnology AG from 2013 to 2014.
Mr. Alder was a Partner at Cooley Godward LLP from 1997 to 2006 and a Partner-Life Sciences Transactions Practice at Cooley LLP from 1997 to 2006.
He also held positions as the Secretary, SVP-Administration & General Counsel at Amgen Rockville, Inc. from 2006 to 2012 and as the Executive Vice President at Sucampo Pharmaceuticals LLC in 2014.
Additionally, Mr. Alder was the Secretary, Chief Business Officer & Senior VP at Autolus Therapeutics Plc from 2017 to 2021 and the General Counsel & EVP-Corporate Development at Micromet Inc.Mr. Alder obtained his graduate degree from the University of Miami in 1990 and his graduate degree from the University of Basel in 1988.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC.
0.13% | 26/03/2024 | 21 140 ( 0.13% ) | 79 698 $ | 31/03/2024 |
Posizioni attive di Matthias Alder
| Società | Posizione | Inizio |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Chief Executive Officer | 20/09/2022 |
| Zurich Bar Association | Corporate Officer/Principal | - |
| The Virginia Bar Association | Corporate Officer/Principal | - |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Chief Executive Officer | 01/09/2022 |
Alliance For Artificial Intelligence In Healthcare
 Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services The Alliance for Artificial Intelligence in Healthcare (AAIH) is an advocacy organization that aims to improve patient outcomes and minimize healthcare costs through the discovery, development, and delivery of better solutions. The private company is based in Long Island City, NY, and was founded by Brandon Allgood. The organization fosters creativity, collaboration, and knowledge sharing among its members, who come from diverse backgrounds in science, math, technology, and healthcare. AAIH is focusing on two primary practice areas in 2023: developing a comprehensive framework for digitizing IND and addressing core challenges in data accessibility through a real-world data registry. | Director/Board Member | - |
Autolus Holdings (UK) Ltd.
 Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Part of Autolus Therapeutics Plc, Autolus Holdings (UK) Ltd. is a holding British company that operates subsidiaries engaged in pharmaceutical research and development activities. The private company is based in London, UK and was founded in 2018. | Director/Board Member | 16/05/2018 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - |
Precedenti posizioni note di Matthias Alder
| Società | Posizione | Fine |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | General Counsel | 01/08/2018 |
| SUCAMPO PHARMACEUTICALS, INC. | General Counsel | 01/03/2017 |
| ░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Matthias Alder
| University of Miami | Graduate Degree |
| University of Basel | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 14 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
| The Virginia Bar Association | |
| Zurich Bar Association | |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
Autolus Holdings (UK) Ltd.
Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Part of Autolus Therapeutics Plc, Autolus Holdings (UK) Ltd. is a holding British company that operates subsidiaries engaged in pharmaceutical research and development activities. The private company is based in London, UK and was founded in 2018. | Health Technology |
Alliance For Artificial Intelligence In Healthcare
Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services The Alliance for Artificial Intelligence in Healthcare (AAIH) is an advocacy organization that aims to improve patient outcomes and minimize healthcare costs through the discovery, development, and delivery of better solutions. The private company is based in Long Island City, NY, and was founded by Brandon Allgood. The organization fosters creativity, collaboration, and knowledge sharing among its members, who come from diverse backgrounds in science, math, technology, and healthcare. AAIH is focusing on two primary practice areas in 2023: developing a comprehensive framework for digitizing IND and addressing core challenges in data accessibility through a real-world data registry. | Technology Services |
| Micromet Inc. |
- Borsa valori
- Insiders
- Matthias Alder
